Matthew Johnson is the Lead Independent Director at PRO-Spectus, Partner at Akuratemp, and leads Pharmaceutical Commercialization at Ingenium Global.
Matthew operates at the intersection of pharmaceutical commercialization, private equity and healthcare strategy, bringing more than two decades of senior level experience to boards, investors, and CEOs. Throughout his extensive careers, Matthew has led and scaled businesses from early stage startups to multi billion dollar enterprises, with full P&L and M&A responsibility across multiple business segments.
As leading healthcare and commercial strategist, Matthew is highly recognized for his strategic and operational vision. He is currently serving on the Board of Directors and Advisory Boards for several companies operating in the healthcare, data, and specialty logistics industries including BioCareSD, PantheRx, Access Infusion, and Thermal Shippling Logistics.
Matthew holds a BS from Northwestern University, an MBA from Auburn University, and an MS from the California Institute of Technology.
.png)